Professor | 何鸿宾 | 数字化转型顾问

Upload Avatar (500 x 500)

Name

何鸿宾

Contact Information

hhb123@ustc.edu.cn

Language ability

中文, 英语

Province

安徽

University/Lab Affiliation and Title	中国科学技术大学
Faculty	Basic Medical Sciences
Academic Background & Achievements	2013 - 农学学士学位：吉林大学 2018 - 理学博士学位：中国科学技术大学 2018 - 优秀博士学位论文：中国科学技术大学 2018 - 院长优秀奖：中国科学院
Work Experience	2018-2021 - 博士后研究：中国科学技术大学 2021-至今 - 特任副研究员：中国科学技术大学
Awards	2018: 优秀博士学位论文，中国科学技术大学 2018: 院长优秀奖，中国科学院

University/Lab Affiliation and Title

中国科学技术大学

Faculty

Basic Medical Sciences

Academic Background & Achievements

Work Experience

Awards

Areas of Focus	NLRP3炎症小体活化机制探究开发靶向NLRP3治疗相关疾病的治疗策略
Publications	Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity, He H, Jiang H, Chen Y, Ye J, Wang A, Wang C, Liu Q, Liang G, Deng X#, Jiang W#, Zhou R#, 2018 Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders, Jiang H, He H, Chen Y, Huang W, Cheng J, Ye J, Wang A, Tao J, Wang C, Liu Q, Jin T, Jiang W#, Deng X#, Zhou R#, 2017 RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor, Chen Y, He H, Lin B, Chen Y, Deng X, Jiang W#, Zhou R#, 2021 Discovery and optimization of 4-oxo-2-thioxo-thiazolidinones as NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inhibitors, Chen Y, He H, Jiang H*, Li L, Hu Z, Huang H, Xu Q, Zhou R#, Deng X#, 2020

Areas of Focus

NLRP3炎症小体活化机制探究
开发靶向NLRP3治疗相关疾病的治疗策略

Publications

Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity, He H*, Jiang H*, Chen Y*, Ye J, Wang A, Wang C, Liu Q, Liang G, Deng X#, Jiang W#, Zhou R#, 2018
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders, Jiang H*, He H*, Chen Y*, Huang W, Cheng J, Ye J, Wang A, Tao J, Wang C, Liu Q, Jin T, Jiang W#, Deng X#, Zhou R#, 2017
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor, Chen Y*, He H*, Lin B, Chen Y, Deng X, Jiang W#, Zhou R#, 2021
Discovery and optimization of 4-oxo-2-thioxo-thiazolidinones as NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inhibitors, Chen Y*, He H*, Jiang H*, Li L, Hu Z, Huang H, Xu Q, Zhou R#, Deng X#, 2020

Nlrp3 炎症小体活化机制治疗策略疾病靶向研究开发

王宪 - 北京大学

孔炜 - 北京大学

Area of Focus
血管 | 微环境 | 心血管 | 疾病 | 病理生理学 | 研究 | 生物学 | 临床 | 治疗 | 预防

冼勋德 - 北京大学

Area of Focus
心血管 | 分子 | 研究 | 代谢 | 紊乱 | 疾病 | 基因 | 工程 | 仓鼠 | 模型

View All

Personal Information